Automated Insulin Delivery Pumps Improve Quality Of Life For Type 1 Diabetes Patients

Type 1 glucosuria is much prevalent successful Finland than anyplace other successful nan world, affecting astir 50,000 people. New automated insulin transportation pumps person importantly improved glucosuria care, while besides expanding curen costs. A caller study conducted astatine nan University of Eastern Finland and Kuopio University Hospital assessed nan semipermanent cost-effectiveness of automated insulin transportation pumps, comparing them to continuous subcutaneous insulin infusion pump curen mixed pinch continuous glucose monitoring. The study included 336 children and adults pinch type 1 diabetes.

The results showed that automated insulin transportation pumps importantly improved value of life and reduced diabetes-related complications. The quality-adjusted life expectancy accrued by an mean of 2.3 years for individuals utilizing an automated insulin transportation pump. Although nan wide costs of automated insulin transportation pump curen were higher than those of accepted insulin pump treatment, its cost-effectiveness ratio was only 11,184 euros per quality-adjusted life-year, which is good beneath nan mostly accepted willingness-to-pay period of 50,000 euros successful Finland.

This is nan first cost-effectiveness study of automated insulin transportation pumps conducted successful Finland. The results support nan usage of automated insulin transportation pumps for patients pinch type 1 diabetes.